Rezdiffra™ (resmetirom) net sales of $137.3 million As of March 31, 2025, more than 17,000 patients on Rezdiffra Two-year compensated MASH cirrhosis (F4c) data from MAESTRO-NAFLD-1 trial selected as ...

Here, we trace RWE's remarkable evolution from its handwritten roots through technological breakthroughs, methodological advancements, and regulatory milestones that have collectively elevated ...

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

The CHMP recommends conditional marketing authorization for Duvyzat to treat Duchenne muscular dystrophy in patients aged 6 ...

WASHINGTON – The Trump administration ousted the director of the National Security Agency Thursday night, according to top congressional Democrats who decried the firing as making the U.S. less ...